Andere Sprachen Sensus Healthcare, Inc.

Aktien

A2JPJ1

US81728J1097

SRTS

Markt geschlossen - Nasdaq Andere Börsenplätze 22:30:00 24.04.2024			% 5 Tage	% 1. Jan.
3,28 ^USD	-4,37 %		+0,92 %	+38,98 %

08.02.	Transcript : Sensus Healthcare, Inc., Q4 2023 Earnings Call, Feb 08, 2024
08.02.	Sensus Healthcare, Inc. meldet Ergebnis für das vierte Quartal und das Gesamtjahr bis zum 31. Dezember 2023	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Sensus Healthcare to Host First Quarter 2024 Financial Results and Business Update Conference Call on Thursday, May 9, 2024	18.04.
Sensus Healthcare to Participate in the 36th Annual Roth Conference	14.03.
Sensus Healthcare Launches “Fair Deal Agreement” for its SRT-100 Vision™ at the American Academy of Dermatology Annual Meeting	13.03.
Sensus Healthcare Launches “Fair Deal Agreement” for its SRT-100 Vision™ at the American Academy of Dermatology Annual Meeting	13.03.
Sensus Healthcare, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	08.02.
Earnings Flash (SRTS) SENSUS HEALTHCARE Posts Q4 Revenue $12.6M, vs. Street Est of $12.1M	08.02.
Sensus Healthcare Reports Fourth Quarter and Full Year 2023 Financial Results	08.02.
Sensus Healthcare Issued U.S. Patent for SRT-100 Vision® System (IG-SRT) Capabilities	08.02.
Sensus Healthcare Issued U.S. Patent for SRT-100 Vision® System (IG-SRT) Capabilities	08.02.
Sensus Healthcare Collaborates with CureRays to Provide Oversight to Help Customers Assure Patient Safety, Reliability of Outcomes and Conformance with Regulatory Requirements	06.02.
Sensus Healthcare Collaborates with CureRays to Provide Oversight to Help Customers Assure Patient Safety, Reliability of Outcomes and Conformance with Regulatory Requirements	06.02.
Sensus Healthcare Announces Retirement of Director Samuel O’Rear	01.02.
Sensus Healthcare Announces Directors Changes	01.02.
Sensus Healthcare to Host Fourth Quarter and Full Year 2023 Financial Results and Business Update Conference Call on Thursday, February 8, 2024	30.01.
Sensus Healthcare to Host Fourth Quarter and Full Year 2023 Financial Results and Business Update Conference Call on Thursday, February 8, 2024	30.01.
Sensus Healthcare Announces Preliminary 2023 Revenue Exceeds $23 Million	23.01.
Sensus Healthcare Announces Preliminary 2023 Revenue Exceeds $23 Million	23.01.
Sensus Healthcare, Inc. Provides Revenue Guidance for the Fourth Quarter and Full Year Ended December 31, 2023	23.01.
Sensus Healthcare, Inc. Appoints Michael Sardano as A Director, Effective February 1, 2024	18.01.
Tranche Update on Sensus Healthcare, Inc.'s Equity Buyback Plan announced on August 8, 2023.	13.11.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Sensus Healthcare, Inc.

Aktien

A2JPJ1

US81728J1097

SRTS

Andere Sprachen

Filter